Carbon Streaming Announces Appointment of Jonathan Rubenstein as Expert Consultant

(Neo:NETZ.NE),(OTC US:OFSTF),(OTCQB:OFSTF),(Boerse Frankfurt – Freiverkehr:M2Q), TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company“) today announced that it has appointed Jonathan Rubenstein, LLB, as expert consultant to the Company to provide oversight, guidance and strategic direction to the Company for significant litigation. […]

Nutriband Co-Founder Gareth Sheridan Returns as CEO

(NASDAQ:NTRB),(NASDAQ:NTRBW), ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of August 10 until October 27 , Co-Founder and Chairman, Serguei Melnik had taken over the responsibilities of CEO. Mr Sheridan has returned to the position of CEO

interface.ai Expands Leadership Team with Steve Swanston as CRO to Advance its Mission of Transforming Banking Through Agentic AI

SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — interface.ai, the first BankGPT platform powering the most capable AI agents for banks and credit unions, today announced the appointment of Steve Swanston as Chief Revenue Officer (CRO). Swanston's appointment marks a significant milestone in interface.ai's growth journey as the company scales its AI platform and

JPMorgan Announces Cash Distributions for the JPMorgan ETFs

(TSX:JEPI),(TSX:JEPQ), TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the final October 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of record on November 3, 2025 will receive cash distributions payable on November 7, 2025. Details

Helium Evolution Announces Conversion of $8.3 Million Convertible Note Into Common Shares

(TSX-V:HEVI), CALGARY, Alberta, Oct. 27, 2025 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, announces that, in accordance with the automatic conversion provisions of the convertible note agreement as announced on August 26, 2025 with ENEOS Xplora USA Limited (“ENEOS

TECHNATION announces Kevin d’Entremont as President and CEO

Toronto, ON, Oct. 27, 2025 (GLOBE NEWSWIRE) — Today, TECHNATION announced the appointment of Kevin d'Entremont as its President and CEO. Kevin's unique career brings over 25 years of experience in the public and private sectors. Most recently, he served as a partner in McKinsey's Public Sector practice in Canada where he led client development

SD Government, a Gogo Company, receives federal contract to supply airborne communications for US agency

(NASDAQ:GOGO), Broomfield,CO., Oct. 27, 2025 (GLOBE NEWSWIRE) — SD Government (SDG), the division of Gogo (NASDAQ: GOGO) providing satellite communications to global governments, has received a five-year federal contract to deliver multi-band, multi-orbit airborne global satellite communications to a US government agency. The new agreement, initially valued at USD$3 million, is a follow-on from Small

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

(NasdaqGM:HROW), NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the third quarter ended September 30, 2025, on Monday, November 10, 2025, after the market close. The Company will also post its

Lakeland Financial Reports Third Quarter Performance; Net Income Grows by 13% to $26.4 Million, as Net Interest Income Expands by 14%

(NASDAQ:LKFN), WARSAW, Ind., Oct. 27, 2025 (GLOBE NEWSWIRE) — Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $26.4 million for the three months ended September 30, 2025, which represents an increase of $3.1 million, or 13%, compared with net income of $23.3 million for the three

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

(NasdaqGM:KYMR), KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to approved and clinically active therapies KT-579 Phase 1 testing expected to begin in early 2026 WATERTOWN, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ:

Scroll to Top